NEXT FUNDS TOPIX-17 Pharmaceutical ETF (TYO:1621)

Assets	5.19B
Expense Ratio	0.32%
PE Ratio	20.34
Dividend (ttm)	535.00
Dividend Yield	1.67%
Ex-Dividend Date	Jul 14, 2025
Payout Frequency	Annual
Payout Ratio	34.86%
1-Year Return	+28.12%

Volume	79
Open	32,590
Previous Close	32,590
Day's Range	31,980 - 32,590
52-Week Low	23,335
52-Week High	34,180
Beta	0.02
Holdings	33
Inception Date	Mar 21, 2008

About 1621

NEXT FUNDS TOPIX-17 Pharmaceutical ETF is an exchange traded fund launched and managed by Nomura Asset Management Co., Ltd. The fund invests in the public equity markets of Japan. It seeks to invest in the stocks of companies operating in the pharmaceutical sector. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the TOPIX-17 PHARMACEUTICAL Index, by investing in the stocks of companies as per their weightings in the index. NEXT FUNDS TOPIX-17 Pharmaceutical ETF was formed on March 21, 2008 and is domiciled in Japan.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 1621
• Provider: NEXT FUNDS

Performance

1621 had a total return of 28.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.96%.

Top 10 Holdings

92.42% of assets

Name	Symbol	Weight
Takeda Pharmaceutical Company Limited	4502	26.30%
Chugai Pharmaceutical Co., Ltd.	4519	14.70%
Daiichi Sankyo Company, Limited	4568	13.12%
Otsuka Holdings Co., Ltd.	4578	12.55%
Astellas Pharma Inc.	4503	10.61%
Shionogi & Co., Ltd.	4507	6.41%
Eisai Co., Ltd.	4523	3.19%
Ono Pharmaceutical Co., Ltd.	4528	2.69%
Santen Pharmaceutical Co., Ltd.	4536	1.43%
Kyowa Kirin Co., Ltd.	4151	1.43%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 14, 2025	535.000 JPY	Aug 22, 2025
Jul 11, 2024	646.000 JPY	Aug 23, 2024
Jul 13, 2023	392.000 JPY	Aug 23, 2023
Jul 14, 2022	357.000 JPY	Aug 23, 2022
Jul 14, 2021	419.000 JPY	Aug 23, 2021
Jul 14, 2020	877.000 JPY	Aug 21, 2020